Dr. Jarrett is a licensed (clinical) psychologist whose research and clinical expertise is in promoting health and wellness, particularly for patients with mood and related disorders. She specializes in short-term, evidenced-based psychotherapy and focuses on cognitive behavioral therapy. In the Department of Psychiatry at UT Southwestern, Dr. Jarrett collaborates on research, treats patients, teaches, and supervises clinical and/or research activities of trainees. Since 1989 Dr. Jarrett has directed the Psychosocial Research and Depression Clinic where the National Institute of Mental Health (NIMH) has funded her research group across decades. She welcomes collaborators and trainees dedicated to understanding the role of psychosocial factors in the course of health and illness, particularly in mood and related disorders.
A partial listing of Dr. Jarrett’s publications can be found below and a more complete listing is available to interested readers at: http://www.ncbi.nlm.nih.gov/myncbi/robin.jarrett.1/bibliography/41161566/public/?sort=date&direction=ascending.
- Undergraduate School
- University of North Carolina at Chapel Hill (1978), Psychology
- Graduate School
- University of North Carolina at Greensboro (1983)
- University of Mississippi and VA Center Consortium (1984), Clinical Psychology
- Cognitive-behavioral therapy
- Evidence-based psychotherapy
- Mood and related disorders
- Psychosocial factors and interventions that promote health
- Initial Steps to inform selection of continuation cognitive therapy or fluoxetine for higher risk responders to cognitive therapy for recurrent major depressive disorder.
- Vittengl JR, Anna Clark L, Thase ME, Jarrett RB Psychiatry Res 2017 Mar 253 174-181
- Defined symptom-change trajectories during acute-phase cognitive therapy for depression predict better longitudinal outcomes.
- Vittengl JR, Clark LA, Thase ME, Jarrett RB Behav Res Ther 2016 Aug 87 48-57
- Divergent Outcomes in Cognitive-Behavioral Therapy and Pharmacotherapy for Adult Depression.
- Vittengl JR, Jarrett RB, Weitz E, Hollon SD, Twisk J, Cristea I, David D, DeRubeis RJ, Dimidjian S, Dunlop BW, Faramarzi M, Hegerl U, Kennedy SH, Kheirkhah F, Mergl R, Miranda J, Mohr DC, Rush AJ, Segal ZV, Siddique J, Simons AD, Cuijpers P Am J Psychiatry 2016 Feb appiajp201515040492
- Quantifying and Qualifying the Preventive Effects of Acute-Phase Cognitive Therapy: Pathways to Personalizing Care.
- Jarrett RB, Minhajuddin A, Vittengl JR, Clark LA, Thase ME J Consult Clin Psychol 2015 Dec
- Predictors of longitudinal outcomes after unstable response to acute-phase cognitive therapy for major depressive disorder.
- Vittengl JR, Clark LA, Thase ME, Jarrett RB Psychotherapy (Chic) 2015 Jun 52 2 268-77
- Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo.
- Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME JAMA Psychiatry 2013 Sep
- Acute phase cognitive therapy for recurrent major depressive disorder: Who drops out and how much do patient skills influence response?
- Jarrett RB, Minhajuddin A, Kangas JL, Friedman ES, Callan JA, Thase ME Behav Res Ther 2013 Jan 51 4-5 221-230
- Skills of Cognitive Therapy (SoCT): A new measure of patients' comprehension and use.
- Jarrett RB, Vittengl JR, Clark LA, Thase ME Psychological assessment 2011 Feb 578-86
- Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up.
- Jarrett RB, Thase ME Contemp Clin Trials 2010 Jul 31 4 355-77
- Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder.
- Kennard BD, Emslie GJ, Mayes TL, Nightingale-Teresi J, Nakonezny PA, Hughes JL, Jones JM, Tao R, Stewart SM, Jarrett RB J Am Acad Child Adolesc Psychiatry 2008 Dec 47 12 1395-404
Honors & Awards
Association for Behavioral and Cognitive Therapies (2015-2017)
American Psychological Association (2014-2017)
- Certified Consultant and Trainer
Academy of Cognitive Therapy (2013-2017)
Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) (2006)
- Elizabeth H. Penn Professorship in Clinical Psychology
The University of Texas Southwestern Medical Center (2004-2017)
- Fourjay Scholar
The Fourjay Foundation, The Beck Institute, Extramural Training Program (2000)
- Diplomate and Founding Fellow
Academy of Cognitive Therapy (1999-2017)
- Principal Investigator with career awards
Funded by the National Institute of Mental Health
- Association for Psychological Science (2010-2017)
- Editorial Board: Journal of Consulting and Clinical Psychology (2004-2016)
- Dallas Psychological Association (1993-2017)
- Reviewers Reserve [NIMH] (1990-2017)
- Texas Psychological Association (1990-2017)
- International Association for Cognitive Psychotherapy (1989-2017)
- American Psychological Association (1984-2017)
- Association for Behavioral and Cognitive Therapy (1978-2017)